Status:
COMPLETED
A Drug-Drug Interaction Study of Omeprazole and PA21
Lead Sponsor:
Vifor Pharma
Conditions:
Healthy
Eligibility:
All Genders
20-50 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to determine if Omeprazole is affected by PA21.
Eligibility Criteria
Inclusion
- Healthy Volunteers
- Written informed consent
Exclusion
- No significant medical conditions
- Pregnancy
Key Trial Info
Start Date :
September 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT01452906
Start Date
September 1 2011
End Date
December 1 2011
Last Update
December 12 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ACRI - Phase 1
Anaheim, California, United States, 92801